Synthesis and evaluation of Lys 1 (α,γ-Folate)Lys 3 ( 177 Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 809 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

Daniel J. O’Shannessy, Elizabeth B. Somers, Julia D. Maltzman et al. · SpringerPlus · 2012 · 157 citations · Full text

Medicine, Oncology, Pathology +17

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Brian M. Necela, Jennifer A. Crozier, Cathy Andorfer et al. · PLoS ONE · 2015 · 147 citations · Full text

Medicine, Molecular Biology, Oncology +17

Computer-assisted coloring and illuminating based on a region-tree structure

Renata Nascimento, Fabiane Queiroz, Allan Rocha et al. · SpringerPlus · 2012 · 144 citations · Full text

Computing, Visualization, Computer Graphics +16

Folate Receptor α Associated With Triple-Negative Breast Cancer and Poor Prognosis

Zhang Zhang, Jianmin Wang, David Tacha et al. · Archives of Pathology & Laboratory Medicine · 2013 · 126 citations

Medicine, Oncology, Pathology +13